The Ministry of Food and Drug Safety (MFDS) and the Korea Cosmetics Association (KCA) have confirmed 155 violations after examining online advertisements for cosmetics claiming efficacy related to “diet” and “body shape maintenance.”The MFDS and the association checked 322 cases from July 24 to 28 a
JW Pharmaceutical said Monday that JW0061, a Wnt-targeted hair loss treatment, has been selected as a project for the “first national new drug development project in 2023.”The company also signed a research and development (R&D) agreement with the Korea Drug Development Fund (KDDF).Under the agreeme
LG Group, a Korean conglomerate operating a wide range of business including electronics, chemicals, and telecommunications, has announced an intention to expand its bio business globally as a future growth engine.Group Chairman Koo Kwang-mo, while reaffirming his will to develop innovative new drug
Celltrion and Celltrion Healthcare held a board meeting on Monday and decided to repurchase shares to stabilize stock prices to enhance shareholder value and increase confidence in business growth.Celltrion will repurchase a total of 696,865 shares of its own stock for an aggregate purchase price of
Drawing a comparison between the handling of Covid-19 and the Ebola crisis, Former UN Secretary-General Ban Ki-moon emphasized the necessity for global leaders to present a more cohesive approach to mitigate avoidable health repercussions for potential future pandemics.The International Society for
A mislabeling incident occurred in which Celltrion Pharm’s tablets were packaged in Myungmoon Pharm’s medicine containers. Theragen Etex, the contract manufacturer of the product in question, explained that it was a simple mix-up due to an employee’s mistakes.According to the Ministry of Food and Dr
Daewoong Pharmaceutical has added benign masseteric hypertrophy (BMH), commonly known as the square jaw, to the indications for its botulinum toxin (BTX) product, Nabota. It is the first case among BTX products worldwide to win the indication for BMH, the company said.Daewoong said it received the M
Pharos iBio, an AI-backed new drug developer based in Korea, said it would conduct a translational study with Johns Hopkins University School of Medicine to develop a combination therapy using its pipeline PHI-101 to treat relapsed or refractory acute myeloid leukemia (AML). A translational study in
Genetic mutation testing, extensively utilized in breast and lung cancer, has been recently incorporated into the realm of brain tumors, consequently enhancing the precision of treatment for such tumors.Within glioblastoma, acknowledged for possessing the most unfavorable prognosis among malignant b
The 39th annual international conference of the International Society for Quality in Health Care (ISQua), officially kicked off on Sunday with the K-Walking parade around Bongeun Temple near Coex, in southern Seoul.Korea is hosting 2,000 representatives from over 70 countries for the conference high
The International Society for Quality in Health Care (ISQua), a nonprofit organization dedicated to healthcare improvement, will launch its 39th annual international conference in COEX, southern Seoul, this Sunday with a walking parade.Korea will host representatives from over 70 countries, with app
Amid the rapid popularization of botulinum toxin for cosmetic procedures, the number of men who have the procedure is also increasing, data showed.According to the American Society of Plastic Surgeons, more than 260,000 botulinum toxin treatments were performed on men in 2020. The situation in Korea
The Korea Disease Control and Prevention Agency (KCDC) plans to appeal after losing the first trial to cancel the refusal of compensation for a man in his 30s who died after receiving a Covid-19 vaccine.However, the National Assembly Health and Welfare Committee has formally requested that the agenc
Celltrion Group Chairman Seo Jung-jin said that after the merger between the Celltrion Group's three major affiliates is completed, he may look into an initial public offering (IPO) process for Celltrion Holdings controlling Celltrion, Celltrion Healthcare, and Celltrion Pharm.Speaking to about 3,20
GC Biopharma and EuBiologics signed a business agreement to jointly produce EuBiologic's oral cholera vaccine, Euvichol.Accordingly, EuBiologics, the developer and supplier of Euvichol, will be in charge of the early stage production process of Euvichol, and GC Biopharma will be in charge of the fin
Daewoong Pharma said it has submitted a New Drug Application (NDA) to the Saudi Food and Drug Authority (SFDA) for Envlo tablets (ingredient: enavogliflozin), a diabetes treatment and Korea's 36th new drug.The treatment is the first locally developed sodium-glucose cotransporter 2 (SGLT-2) inhibitor
Novartis' Jakavi (ruxolitinib) recently demonstrated improved complete response (CR), event-free survival (EFS), and molecular response in patients with hydroxyurea-resistant or intolerant polycythemia vera (PV), adding to the therapeutic rationale for its hematocrit control shown in licensed trials
It has been confirmed that Medtronic Korea is conducting a manufacturer's recall of its laryngoscope blade, McGRATH MAC 2-Blade, from domestic medical institutions.According to the Ministry of Food and Drug Safety (MFDS), Medtronic Korea is recalling 500 units with specific manufacturing numbers. Un
Boryung said it has terminated its exclusive supply agreement in China for Gelforce, an antacid, with China Sinopharm International Corporation. The total size of the contract was $87.1 million.Boryung had signed the agreement with Sinopharm in August 2021.Under the accord, Boryung would supply Gelf
Celltrion said on Friday that it finalized a U.S. patent settlement with Johnson & Johnson (J&J), for Celltrion’s Stelara (ingredient: ustekinumab) biosimilar, CT-P43.Accordingly, the agreement allows Celltrion's CT-P43 biosimilar to enter the U.S. biosimilar market as a first-in-class product on Ma